Udayavni Special

Russia launched Covid-19 Vaccine ‘Sputnik-V’: Here’s everything you need to know


Team Udayavani, Aug 14, 2020, 12:36 PM IST

Russia became the first country to grant regulatory approval to a Covid-19 vaccine, dubbed “Sputnik V” Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University said that the human trials for the vaccine have been completed at the university and they will be discharged soon

Russian President Putin’s daughter has already been given the jab of Russia’s Covid-19 vaccine. According to ET, Russia’s trials allowed for the civil use and inoculation of the vaccine while simultaneously conducting late-stage trials. Epidemiologists and medical experts, including the WHO believe that such a move can put people at risk.

How will the vaccine work?

Based on the DNA of a SARS-CoV-2 type adenovirus, it uses the weakened virus to deliver small parts of pathogen and stimulate and immune response. The vaccine would be administered in two shots, 21 days apart

Clinical trial

The Quint reports state that clinical trials of the vaccine began on 18 June with 38 volunteers who developed immunity. Another trial was started on 20 July. The trials were conducted at 7 sites across the country.

Who will receive the vaccine first?

Reports suggests that doctors and teachers would be among the first groups to vaccinated. Also, Russia’s elite has been given the experimental  vaccine. Russia has received several foreign requests for 1 billion doses.

Kirill Dmitriev, head of the RIFF said that more than 20 countries have shown interest in the Russia’s vaccine.

 

Production of the vaccine

Sources claim that Russia’s first potential vaccine will be approved by regulators this month and production is all set to begin September. Also, reports suggest that on 1 August, Health Minister Murashko said that Russian plans on starting a mass vaccination campaign against the novel coronavirus in October.

Skepticism about the Russian Vaccine?

However, World Health Organisation (WHO) has said they don’t have enough information about the Russian vaccine to evaluate its potency against Covid-19 pandemic. According to Indian Express, AIIMS director Randeep Guleria said, “We will have to see critically whether it is safe and effective. There should not be any side effects of the vaccine and it should provide good immunity and protection. India has the capacity for mass production of vaccine.”

Top News

K’taka BJP MLAs come to blows in Assembly

Tablighi Jamaat event caused COVID-19 to spread: MHA to RS

8 MPs suspended from RS for a week over uproar on Farm Bill

SC cancels NLSIU Bengaluru entrance exam NLAT-2020

Maha: 10 killed in Bhiwandi building collapse; 11 rescued

UN report on presence of ISIS terrorists in Kerala, Karnataka incorrect: Govt in LS

K’taka COVID-19 update: 8191 new cases, 8611 discharges, 101 deaths on Sep 19




Related Articles More

Tablighi Jamaat event caused COVID-19 to spread: MHA to RS

86,961 new COVID-19 cases in India, tally reaches 54,87,580; death toll mounts to 87,882

India, Maldives will support each other in fight against health, economic impact of COVID-19: Modi

In a first, Asha worker dies of Covid-19 in state

K’taka COVID-19 update: 8191 new cases, 8611 discharges, 101 deaths on Sep 19

MUST WATCH

Fight between bjp leadres in Vidhana soudha

The river has shifted its direction due to flood

Easiest Way to Grow Sugarcane | Farming Guide in Kannada

Udupi: Rains to continue for 2 more days; DC orders evacuation

Shirva: Heavy rains allow Bhagini offering after 70 years at Nadibettu

Latest Additions

Who is Payal Ghosh, the actress who has accused Anurag Kashyap of sexual harassment?

Border standoff: Army commanders of India, China hold 6th round of talks

K’taka BJP MLAs come to blows in Assembly

SC stays HC order granting bail to ex-UP minister in gang rape case

India vs China: Big blow to China as Indian Army takes control of six major heights on LAC

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.